UPDATE 1-Europe backs nuclear medicine for cancer that killed Steve Jobs
July 21, 2017 at 12:15 PM EDT
LONDON, July 21 (Reuters) - A nuclear medicine targeting the type of cancer that killed Steve Jobs won a green light from EU regulators on Friday, boosting prospects for its developer Advanced Accelerator Applications.
